TW255886B - - Google Patents

Info

Publication number
TW255886B
TW255886B TW083103432A TW83103432A TW255886B TW 255886 B TW255886 B TW 255886B TW 083103432 A TW083103432 A TW 083103432A TW 83103432 A TW83103432 A TW 83103432A TW 255886 B TW255886 B TW 255886B
Authority
TW
Taiwan
Prior art keywords
compound
general formula
lower alkyl
cycloalkyl
alkyl
Prior art date
Application number
TW083103432A
Other languages
English (en)
Chinese (zh)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of TW255886B publication Critical patent/TW255886B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
TW083103432A 1993-04-16 1994-04-18 TW255886B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
TW255886B true TW255886B (enExample) 1995-09-01

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103432A TW255886B (enExample) 1993-04-16 1994-04-18

Country Status (13)

Country Link
US (1) US5488134A (enExample)
EP (1) EP0646570B1 (enExample)
JP (1) JP3411036B2 (enExample)
KR (1) KR100277242B1 (enExample)
CN (1) CN1046937C (enExample)
AT (1) ATE167662T1 (enExample)
AU (1) AU666819B2 (enExample)
CA (1) CA2138264C (enExample)
DE (1) DE69411243T2 (enExample)
DK (1) DK0646570T3 (enExample)
ES (1) ES2119190T3 (enExample)
TW (1) TW255886B (enExample)
WO (1) WO1994024087A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
ATE233764T1 (de) 1997-09-29 2003-03-15 Meiji Seika Kaisha Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
US6562860B1 (en) 1998-12-23 2003-05-13 G. D. Searle & Co. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
WO2000038723A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
KR20010099937A (ko) 1998-12-23 2001-11-09 윌리암스 로저 에이 심혈관 징후용 콜레스테릴 에스테르 전달 단백질 억제제및 피브르산 유도체의 조합물
EP1336413A1 (en) 1998-12-23 2003-08-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
CA2356422C (en) 1998-12-23 2008-09-16 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
WO2000038722A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
PT1140184E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com derivados de acido nicotinico para indicacoes cardiovasculares
US6586434B2 (en) 2000-03-10 2003-07-01 G.D. Searle, Llc Method for the preparation of tetrahydrobenzothiepines
AU2001247331A1 (en) * 2000-03-10 2001-09-24 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
CA2464685A1 (en) 2001-11-02 2003-05-15 G.D. Searle Llc Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
CA2471639A1 (en) 2002-01-17 2003-07-31 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CN104023718B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗高胆血症和胆汁淤积性肝病的胆汁酸再循环抑制剂
ES2633766T3 (es) 2011-10-28 2017-09-25 Lumena Pharmaceuticals Llc Inhibidores de reciclaje de ácido biliar para el tratamiento de enfermedades de hígado colestático pediátrico
US20140271734A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
WO2014144650A2 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
JP7562546B2 (ja) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0701991T3 (da) * 1991-10-17 1999-09-13 Shionogi & Co Fremgangsmåde til fremstilling af lignananaloger og udgangsmaterialer dertil

Also Published As

Publication number Publication date
ATE167662T1 (de) 1998-07-15
AU6437994A (en) 1994-11-08
CN1046937C (zh) 1999-12-01
EP0646570A1 (en) 1995-04-05
DK0646570T3 (da) 1998-10-26
WO1994024087A1 (fr) 1994-10-27
EP0646570B1 (en) 1998-06-24
CN1109685A (zh) 1995-10-04
JP3411036B2 (ja) 2003-05-26
DE69411243T2 (de) 1998-11-19
AU666819B2 (en) 1996-02-22
US5488134A (en) 1996-01-30
DE69411243D1 (de) 1998-07-30
KR950701902A (ko) 1995-05-17
ES2119190T3 (es) 1998-10-01
CA2138264A1 (en) 1994-10-27
EP0646570A4 (en) 1995-08-09
CA2138264C (en) 2004-04-06
KR100277242B1 (ko) 2001-02-01

Similar Documents

Publication Publication Date Title
TW255886B (enExample)
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
AU6326890A (en) Improvements in or relating to organic compounds
TW223645B (enExample)
EP0405864A3 (en) Phospholipase a2 inhibitor, microorganisms producing said inhibitor and processes for its production
AU1120095A (en) Novel imidazole derivative and process for producing the same
EP0554455A4 (enExample)
AU2722095A (en) Novel pyrrolocarbazoles
EP0712843A4 (en) VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
GR3025599T3 (en) the same Carbazolone derivatives and process for preparing
GR3006060T3 (enExample)
AU8460791A (en) Compound, preparation and use
EP0601191A4 (en) Novel tetracyclic compound.
AU2406097A (en) Process for the preparation of tetrahydro-indolizines
IL119331A (en) Method for preparing alpha, beta-unsaturated-beta-trifluoromethyl carboxylates and related compounds
GR3032474T3 (en) Selective dehalogenation method
EP0331073A3 (en) Benzhydrylamine derivatives
GR3034291T3 (en) Catalyst with improved activity for ethylene (co)-polymerization
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
GR3004216T3 (enExample)
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
GR3021427T3 (en) Indole derivative
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees